Catalent to Expand Kentucky Controlled-release Drug Manufacturing Facility
Catalent Pharma Solutions, a drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky.
The company is to invest nearly $35 million to expand the 100,000 square-foot facility by almost 80,000 square feet, and will add as many as 90 new employees at the expanded site.
Construction will commence on June 12, 2013 with a ceremony led by Kentucky Governor Steve Beshear and Catalent President and CEO John Chiminski.
Catalent expects to complete the expansion by October 2014, and will welcome customers to tour the facility at that time.
The Winchester expansion comes on the heels of several significant investments Catalent has made in advanced delivery technologies globally. Mr. Chiminski notes, "As with Winchester, Catalent continues to invest to meet the most critical needs of the industry, including recently announced inhalation facility expansion in North Carolina, our recently completed biologics expansion in Wisconsin, and our two new ventures in China, which will focus on softgel technologies and clinical trial supplies."
